Company
Olympus
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
159
510(k), De Novo and PMA
Device trials
31
As lead sponsor, any status
Adverse event reports
160,301
Received Nov 1, 2025 to Nov 19, 2026
Recall records
603
One per recalled product
Olympus is on our public-company list (ticker 7733.T). Names searched as well: Olympus Medical Systems. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.
Listed
7733.T
Listed outside the US
Public float
Unknown
Not reported in US filings
Revenue
Not reported
Net income
Not reported
R&D spending
Not reported
Cash
Not reported
Long-term debt
Not reported
Shares outstanding
Not reported
Private placements (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
Company details
From the company's latest Form D.
- Legal name
- Olympus Ascent Investors, LLC; Olympus Topco, Inc.
- Headquarters
- Salt Lake City, Utah
- Incorporated
- Delaware in 2019
- Entity type
- Limited Liability Company
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1801912 ↗, CIK 1683269 ↗
Executives, directors and promoters
As listed on the latest Form D.
3 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Olympus.
Latest FDA decisions
The 8 newest of 159 since 2015.
K262877 · Decided Sep 16, 2026 · 30 days after receipt
Device type: Powered Laser Surgical Instrument (GEX) · General & Plastic Surgery
K262079 · Decided Sep 10, 2026 · 80 days after receipt
Device type: Endoscopic Video Imaging System/Component, Gastroenterology-Urology (FET) · GI, Urology & Nephrology
K260401 · Decided Aug 27, 2026 · 202 days after receipt
Device type: Ultrasound Bronchoscope (PSV) · Radiology & Imaging
156 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT06592820 · 300 participants (planned) · Start Sep 3, 2025 · Primary completion Nov 28, 2028
Device: Endoscopic Ultrasound Shear Wave Elastography (EUS) and Attenuation Imaging; FibroScan and 1 more · For: MASLD; MASH; Fibrosis, Liver and 1 more
Sites: Newport Beach, California; Boston, Massachusetts; Danville, Pennsylvania
- STRIVE Post-Market Registry StudyRecruiting
NCT04302272 · 150 participants (planned) · Start Oct 9, 2021 · Primary completion Dec 2026
Device: Spiration Valve System (SVS) · For: Emphysema
Sites: Phoenix, Arizona; Mountain View, California; Coral Gables, Florida · 16 sites in all
- Modified SOLTIVE StudyNot yet recruiting
NCT07838077 · 250 participants (planned) · Start Nov 2026 · Primary completion May 2028
Device: SOLTIVE Premium SuperPulsed Laser System · For: Calculi, Renal; Calculi, Urinary; Benign Prostatic Hyperplasia
Sites: Kansas City, Kansas
28 more trials with a free account
Reports received
160,301
Received Nov 1, 2025 to Nov 19, 2026. Includes 3 of another or unstated type.
Malfunction reports
159,360
99% of reports
Injury reports
919
0.6% of reports
Death reports
19
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 3,853 | 312 | 8 | 0 |
| Jan 24 | 3,953 | 281 | 9 | 0 |
| Feb 24 | 4,089 | 296 | 11 | 0 |
| Mar 24 | 4,586 | 310 | 2 | 0 |
| Apr 24 | 4,641 | 152 | 9 | 0 |
| May 24 | 4,947 | 149 | 2 | 0 |
| Jun 24 | 4,724 | 209 | 2 | 0 |
| Jul 24 | 5,102 | 191 | 4 | 0 |
| Aug 24 | 4,809 | 190 | 4 | 1 |
| Sep 24 | 4,751 | 144 | 4 | 0 |
| Oct 24 | 5,670 | 154 | 17 | 0 |
| Nov 24 | 3,080 | 217 | 3 | 0 |
| Dec 24 | 3,064 | 178 | 0 | 0 |
| Jan 25 | 3,654 | 158 | 3 | 0 |
| Feb 25 | 4,945 | 145 | 3 | 0 |
| Mar 25 | 4,806 | 120 | 1 | 0 |
| Apr 25 | 5,187 | 116 | 1 | 0 |
| May 25 | 4,517 | 144 | 2 | 0 |
| Jun 25 | 5,079 | 138 | 2 | 0 |
| Jul 25 | 6,197 | 111 | 4 | 0 |
| Aug 25 | 6,437 | 99 | 2 | 0 |
| Sep 25 | 6,993 | 86 | 1 | 0 |
| Oct 25 | 10,538 | 175 | 2 | 0 |
| Nov 25 | 10,176 | 87 | 0 | 0 |
| Dec 25 | 14,761 | 114 | 2 | 0 |
| Jan 26 | 14,295 | 79 | 0 | 0 |
| Feb 26 | 11,356 | 84 | 0 | 0 |
| Mar 26 | 12,687 | 71 | 2 | 0 |
| Apr 26 | 15,448 | 64 | 0 | 0 |
| May 26 | 14,625 | 106 | 1 | 0 |
| Jun 26 | 13,182 | 65 | 2 | 0 |
| Jul 26 | 13,687 | 78 | 3 | 0 |
| Aug 26 | 13,939 | 34 | 2 | 3 |
| Sep 26 | 14,141 | 71 | 3 | 0 |
| Oct 26 | 11,063 | 66 | 4 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Olympus Tripp-Lite P580-025 25ft DisplayPort Cable, Model Number P580-025, an accessory used in conjunction wtih OLYSENSE Hub SystemOpen, Classified
Z-3329-2026 · Started Aug 27, 2026 · Posted by FDA Sep 29, 2026
Reason given: While in the high-power operating mode, a video dropout/blackout may occur when using a particular accessory cable.
Cause as FDA categorized it: Under Investigation by firm
Z-3299-2026 · Started Aug 24, 2026 · Posted by FDA Sep 25, 2026
Reason given: There are identified discrepancies between the sterilization parameters listed in the Instructions for Use and the sterilization parameters listed in the Japanese package insert.
Cause as FDA categorized it: Process control · Device type: Hysteroscope (And Accessories) (HIH)
Z-3300-2026 · Started Aug 24, 2026 · Posted by FDA Sep 25, 2026
Reason given: There are identified discrepancies between the sterilization parameters listed in the Instructions for Use and the sterilization parameters listed in the Japanese package insert.
Cause as FDA categorized it: Process control · Device type: Hysteroscope (And Accessories) (HIH)
600 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.